Federal Register / Vol. 74, No. 182 / Tuesday, September 22, 2009 / Notices 48269 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent within 30 days of this notice to 

the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov 

or by fax to 202–395–6974. Please direct 

all correspondence to the ‘‘attention of 

the desk officer for HRSA.’’ 

Dated: September 15, 2009. 

Alexandra Huttinger, 

Director, Division of Policy Review and 

Coordination. 

[FR Doc. E9–22813 Filed 9–21–09; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: 

Comment Request 

In compliance with the requirement 

for opportunity for public comment on 

proposed data collection projects 

(section 3506(c)(2)(A) of Title 44, United 

States Code, as amended by the 

Paperwork Reduction Act of 1995, 

Public Law 104–13), the Health 

Resources and Services Administration 

(HRSA) publishes periodic summaries 

of proposed projects being developed 

for submission to the Office of 

Management and Budget (OMB) under 

the Paperwork Reduction Act of 1995. 

To request more information on the 

proposed project or to obtain a copy of 

the data collection plans and draft 

instruments, e-mail 

paperwork@hrsa.gov or call the HRSA 

Reports Clearance Officer on (301) 443– 

1129. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency; (b) the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project: Drug Pricing Program 

Reporting Requirements (OMB No. 

0915–0176)—[Extension] 

Section 602 of Public Law 102–585, 

the Veterans Health Care Act of 1992, 

enacted section 340B of the Public 

Health Service Act (PHS Act) 

‘‘Limitation on Prices of Drugs 

Purchased by Covered Entities.’’ Section 

340B provides that a manufacturer who 

sells covered outpatient drugs to eligible 

entities must sign a pharmaceutical 

pricing agreement with the Secretary of 

Health and Human Services in which 

the manufacturer agrees to charge a 

price for covered outpatient drugs that 

will not exceed an amount determined 

under a statutory formula. Covered 

entities which choose to participate in 

the section 340B drug discount program 

must comply with the requirements of 

340B(a)(5) of the PHS Act. Section 

340B(a)(5)(A) prohibits a covered entity 

from accepting a discount for a drug that 

would also generate a Medicaid rebate. 

Further, section 340B(a)(5)(B) prohibits 

a covered entity from reselling or 

otherwise transferring a discounted drug 

to a person who is not a patient of the 

entity. 

In response to the statutory mandate 

of section 340B(a)(5)(C) to develop audit 

guidelines and because of the potential 

for disputes involving covered entities 

and participating drug manufacturers, 

the HRSA Office of Pharmacy Affairs 

(OPA) developed a dispute resolution 

process for manufacturers and covered 

entities as well as manufacturer 

guidelines for audit of covered entities. 

The annual estimate of burden is as 

follows: 

Instrument Number of 

respondents 

Responses 

per 

respondent 

Total 

responses 

Hours per 

response 

Total 

burden hours 

Audits 

Audit Notification of Entity .................................................... 2 1 2 4 8 

Audit Work Plan ................................................................... 1 1 1 8 8 

Audit Report ......................................................................... 1 1 1 1 1 

Entity Response ................................................................... 0 0 0 0 0 

Dispute Resolution 

Dispute Resolution Request ................................................ 2 4 8 10 80 

Rebuttal ................................................................................ 2 1 2 16 32 

Recordkeeping Requirement 

Dispute Records .................................................................. 10 1 10 .5 5 

Total Recordkeeping ............................................................ 10 ........................ ........................ ........................ 5 

E-mail comments to 

paperwork@hrsa.gov or mail the HRSA 

Reports Clearance Officer, Room 10–33, 

Parklawn Building, 5600 Fishers Lane, 

Rockville, MD 20857. Written comments 

should be received within 60 days of 

this notice. 

Dated: September 15, 2009. 

Alexandra Huttinger, 

Director, Division of Policy Review and 

Coordination. 

[FR Doc. E9–22811 Filed 9–21–09; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 


sroberts on DSKD5P82C1PROD with NOTICES
48270 Federal Register / Vol. 74, No. 182 / Tuesday, September 22, 2009 / Notices 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Oncology 1–Basic 

Translational Integrated Review Group, 

Cancer Etiology Study Section. 

Date: October 12–13, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Mayflower Park Hotel, 405 Olive 

Way, Seattle, WA 98101. 

Contact Person: Cathleen L. Cooper, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4208, 

MSC 7812, Bethesda, MD 20892, 301–443– 

4512, cooperc@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group, Molecular 

Neuropharmacology and Signaling Study 

Section. 

Date: October 12–13, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Deborah L. Lewis, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1224, lewisdeb@csr.nih.gov. 

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences, Integrated Review Group, 

Skeletal Biology Development and Disease 

Study Section. 

Date: October 12–13, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Priscilla B. Chen, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4104, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1787, chenp@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Pilot Clinical 

Applications Urology and Nephrology. 

Date: October 12–13, 2009. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Ryan G. Morris, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4205, 

MSC 7814, Bethesda, MD 20892, 301–435– 

1501, morrisr@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences, Integrated Review Group, 

Molecular and Cellular Endocrinology Study 

Section. 

Date: October 12, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 West 

Mission Bay Drive, San Diego, CA 92109. 

Contact Person: David Weinberg, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6170, 

Bethesda, MD 20892, 301–435–1044, 

David.Weinberg@nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes, Integrated Review 

Group, Language and Communication Study 

Section. 

Date: October 12, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Weijia Ni, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3184, MSC 7848, Bethesda, MD 

20892, (301) 435–1507. niw@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, AcademicIndustry Partnership in Cancer Imaging. 

Date: October 12, 2009. 

Time: 12 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Antonio Sastre, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5215, 

MSC 7412, Bethesda, MD 20892, 301–435– 

2592, sastrea@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems, Integrated Review 

Group, Gastrointestinal Mucosal 

Pathobiology Study Section. 

Date: October 13–14, 2009. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Peter J. Perrin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

0682, perrinp@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior, Integrated Review Group, 

Risk, Prevention and Intervention for 

Addictions Study Section. 

Date: October 13–14, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Gabriel B. Fosu, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rocklege Drive, Room 3108 

MSC 7808, Bethesda, MD 20892, (301) 435– 

3562, fosug@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems, Integrated Review 

Group, Cellular and Molecular Biology of the 

Kidney Study Section. 

Date: October 13, 2009. 

Time: 8 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Bonnie L. Burgess-Beusse, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1783, beusseb@mail.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience, 

Integrated Review Group, Sensorimotor 

Integration Study Section. 

Date: October 13, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, NW., Washington, DC 

20037. 

Contact Person: John Bishop, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5180, 

MSC 7844, Bethesda, MD 20892. (301) 435– 

1250. bishopj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Gene 

Therapy Member Conflict. 

Date: October 13, 2009. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Syed M. Quadri, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6210, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1211, quadris@csr.nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences, Integrated Review 

Group, Electrical Signaling, Ion Transport, 

and Arrhythmias Study Section. 

Date: October 13–14, 2009. 

Time: 5 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Avenue, NW., Washington, DC 20037. 

Contact Person: Rajiv Kumar, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 


sroberts on DSKD5P82C1PROD with NOTICES
Federal Register / Vol. 74, No. 182 / Tuesday, September 22, 2009 / Notices 48271 

Health, 6701 Rockledge Drive, Room 4122, 

MSC 7802, Bethesda, MD 20892. 301–435– 

1212. kumarra@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Oncology 

1—Basic and Translational, Special 

Emphasis Panel. 

Date: October 13, 2009. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: AngeI Y. Ng, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6200, 

MSC 7804, (For courier delivery, use MD 

20817) Bethesda, MD 20892, 301–435–1715, 

nga@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, NOT–OD– 

09–058 (CE): Enabling RPGs to Leverage, 

NCRR Center Programs. 

Date: October 13, 2009. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Mayflower Park Hotel, 405 Olive 

Way, Seattle, WA 98101. 

Contact Person: Cathleen L. Cooper, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4208, 

MSC 7812, Bethesda, MD 20892, 301–443– 

4512, cooperc@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics, Integrated 

Review Group, Macromolecular Structure 

and Function E Study Section. 

Date: October 14, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Churchill Hotel, 1914 

Connecticut Avenue, NW., Washington, DC 

20009. 

Contact Person: Nitsa Rosenzweig, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1102, 

MSC 7760, Bethesda, MD 20892, (301) 435– 

1747, rosenzweign@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group, 

Genomics, Computational Biology and 

Technology Study Section. 

Date: October 14–15, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Mayflower Park Hotel, 405 Olive 

Way, Seattle, WA 98101. 

Contact Person: Barbara J. Thomas, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2218, 

MSC 7890, Bethesda, MD 20892, 301–435– 

0603, bthomas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Program 

Project: Cell Biology. 

Date: October 14–15, 2009. 

Time: 10 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting). 

Contact Person: Steven Nothwehr, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5183, 

MSC 7840, Bethesda, MD 20892, 301–435– 

2492, nothwehrs@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Electromagnetic Devices. 

Date: October 14, 2009. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Antonio Sastre, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5215, 

MSC 7412, Bethesda, MD 20892, 301–435– 

2592, sastrea@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics, Integrated 

Review Group, Biochemistry and Biophysics 

of Membranes Study Section. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC 20036. 

Contact Person: Nuria E. Assa-Munt, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4164, 

MSC 7806, Bethesda, MD 20892, (301) 451– 

1323, assamunu@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Topics in 

Virology. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 9 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: John C. Pugh, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

2398, pughjohn@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience, Integrated 

Review Group, Neurogenesis and Cell Fate 

Study Section. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Allerton Hotel, 701 North 

Michigan Avenue, Chicago, IL 60611. 

Contact Person: Lawrence Baizer, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1257, baizerl@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group, Cellular Signaling 

and Regulatory Systems Study Section. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Elena Smirnova, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5187, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1236, smirnove@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies, Integrated Review 

Group, Biodata Management and Analysis 

Study Section. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Nikko San Francisco, 222 

Mason Street, San Francisco, CA 94102. 

Contact Person: George W. Chacko, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4186, 

MSC 7806,Bethesda, MD 20892, 301–435– 

1245, chackoge@csr.nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences, Integrated Review 

Group, Clinical and Integrative 

Cardiovascular Sciences Study Section. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Avenue, NW., Washington, DC 20037. 

Contact Person: Russell T. Dowell, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4128, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1850, dowellr@csr.nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences, Integrated Review 

Group, Cardiovascular Differentiation and 

Development Study Section. 

Date: October 15, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Maqsood A. Wani, PhD, 

DVM, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4136, 

MSC 7814, Bethesda, MD 20892, 301–435– 

2270, wanimaqs@csr.nih.gov. 

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences, Integrated Review Group, 

Musculoskeletal Tissue Engineering Study 

Section. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 


sroberts on DSKD5P82C1PROD with NOTICES
48272 Federal Register / Vol. 74, No. 182 / Tuesday, September 22, 2009 / Notices 

Contact Person: Jean D. Sipe, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4106, 

MSC 7814, Bethesda, MD 20892, 301/435– 

1743, sipej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Topics in 

Bacterial Pathogenesis. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 West 

Mission Bay Drive, San Diego, CA 92109. 

Contact Person: RoIf Menzel, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3196, 

MSC 7808, Bethesda, MD 20892, 301–435– 

0952, menzelro@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology, Integrated Review Group, 

Pathogenic Eukaryotes Study Section. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Baltimore Marriott Waterfront, 700 

Aliceanna Street, Baltimore, MD 21202. 

Contact Person: Tera Bounds, DVM, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3198, 

MSC 7808, Bethesda, MD 20892, 301 435– 

2306, boundst@csr.nih.gov. 

Name of Committee: Vascular and 

Hematology Integrated Review Group, 

Atherosclerosis and Inflammation of the 

Cardiovascular System Study Section. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Madison Hotel, 1177 15th 

Street, NW., Washington, DC 20001. 

Contact Person: Larry Pinkus, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4132, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1214, pinkusl@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems, Integrated Review 

Group, Pathobiology of Kidney Disease Study 

Section. 

Date: October 15, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Mushtaq A. Khan, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2176, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1778, khanm@csr.nih.gov. 

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences, Integrated Review Group, 

Skeletal Muscle and Exercise Physiology 

Study Section. 

Date: October 15–16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Daniel F. McDonald, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4110, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1215, mcdonald@csr.nih.gov. 

Name of Committee: Vascular and 

Hematology Integrated Review Group, 

Erythrocyte and Leukocyte Biology Study 

Section. 

Date: October 15, 2009. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC 20036. 

Contact Person: Delia Tang, MD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 4126, MSC 7802, Bethesda, MD 

20892, 301–435–2506, tangd@csr.nih.gov. 

Name of Committee: Vascular and 

Hematology Integrated Review Group, 

Hemostasis and Thrombosis Study Section. 

Date: October 15, 2009. 

Time: 8 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike Maddison, Rockville, MD 

20852. 

Contact Person: Bukhtiar H. Shah, PhD, 

DVM, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4120, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1233, shahb@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience, Integrated 

Review Group, Neurotransporters, Receptors, 

and Calcium Signaling Study Section. 

Date: October 15–16, 2009. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Palomar Hotel, 2121 P Street, NW., 

Washington, DC 20037. 

Contact Person: Peter B. Guthrie, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4182, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1239, guthriep@csr.nih.gov. 

Name of Committee: Immunology 

Integrated Review Group, Cellular and 

Molecular Immunology—B Study Section. 

Date: October 15–16, 2009. 

Time: 8:30 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Allerton Hotel, 701 North 

Michigan Avenue, Chicago, IL 60611. 

Contact Person: Betty Hayden, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4206, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1223, haydenb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Chemical 

and Bioanalytical Sciences Fellowship Panel. 

Date: October 15, 2009. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Denise Beusen, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4142, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1267, beusend@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group, Genetic 

Variation and Evolution Study Section. 

Date: October 15–16, 2009. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The River Inn, 924 25th Street, NW., 

Washington, DC 20037. 

Contact Person: David J. Remondini, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2210, 

MSC 7890, Bethesda, MD 20892, 301–435– 

1038, remondid@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflicts in Biological Chemistry and 

Macromolecular Biophysics. 

Date: October 15–16, 2009. 

Time: 11 a.m. to 10 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Donald L. Schneider, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5160, 

MSC 7842, Bethesda, MD 20892, (301) 435– 

1727, schneidd@csr.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology, Integrated Review Group, 

Neurological, Aging and Musculoskeletal 

Epidemiology Study Section. 

Date: October 15–16, 2009. 

Time: 8:30 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel, Washington, DC, 

1515 Rhode Island Avenue, NW., 

Washington, DC 20005. 

Contact Person: Heidi B. Friedman, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1012A, 

MSC 7770, Bethesda, MD 20892, 301–435– 

1721, hfriedman@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel, 

Bioengineering Research Partnerships and 

Imaging Member Conflicts. 

Date: October 16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Grand Hyatt Seattle, 721 Pine Street, 

Seattle, WA 98101. 

Contact Person: John Firrell, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5213, 


sroberts on DSKD5P82C1PROD with NOTICES
Federal Register / Vol. 74, No. 182 / Tuesday, September 22, 2009 / Notices 48273 

MSC 7854, Bethesda, MD 20892, 301–435– 

2598, firrellj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Topics on 

Control of Fungal Infections. 

Date: October 16, 2009. 

Time: 8 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Baltimore Marriott Waterfront, 700 

Aliceanna Street, Baltimore, MD 21202. 

Contact Person: Tera Bounds, DVM, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3214, 

MSC 7808, Bethesda, MD 20892, 301–435– 

2306, boundst@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Fellowships: 

Biomedical Imaging and Bioengineering. 

Date: October 16, 2009. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Dharam S. Dhindsa, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5110, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

1174, dhindsad@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 14, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–22592 Filed 9–21–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

Pulmonary-Allergy Drugs Advisory 

Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: PulmonaryAllergy Drugs Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on November 19, 2009, from 8 a.m. 

to 5 p.m. 

Location: Hilton Washington DC/ 

Silver Spring, The Ballrooms, 8727 

Colesville Rd., Silver Spring, MD. The 

hotel phone number is 301–589–5200. 

Contact Person: Kristine T. Khuc, 

Center for Drug Evaluation and Research 

(HFD–21), Food and Drug 

Administration, 5600 Fishers Lane (for 

express delivery, 5630 Fishers Lane, rm. 

1093), Rockville, MD 20857, 301–827– 

7001, FAX: 301–827–6776, e-mail: 

Kristine.Khuc@fda.hhs.gov, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington, DC area), code 

3014512545. Please call the Information 

Line for up-to-date information on this 

meeting. A notice in the Federal 

Register about last minute modifications 

that impact a previously announced 

advisory committee meeting cannot 

always be published quickly enough to 

provide timely notice. Therefore, you 

should always check the agency’s Web 

site and call the appropriate advisory 

committee hot line/phone line to learn 

about possible modifications before 

coming to the meeting. 

Agenda: The committee will discuss 

the efficacy supplement for new drug 

application (sNDA) 21–395, for the 

approved product Spiriva HandiHaler 

(tiotropium inhalation powder), 

manufactured by Boehringer Ingelheim, 

for the reduction in exacerbations 

(worsening of symptoms) in patients 

with chronic obstructive pulmonary 

disease (COPD). 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ 

AdvisoryCommittees/Calendar/ 

default.htm. Scroll down to the 

appropriate advisory committee link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before November 4, 2009. 

Oral presentations from the public will 

be scheduled between approximately 1 

p.m. and 2 p.m. Those desiring to make 

formal oral presentations should notify 

the contact person and submit a brief 

statement of the general nature of the 

evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before October 27, 2009. Time 

allotted for each presentation may be 

limited. If the number of registrants 

requesting to speak is greater than can 

be reasonably accommodated during the 

scheduled open public hearing session, 

FDA may conduct a lottery to determine 

the speakers for the scheduled open 

public hearing session. The contact 

person will notify interested persons 

regarding their request to speak by 

October 28, 2009. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Kristine 

Khuc at least 7 days in advance of the 

meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/Advisory

Committees/AboutAdvisoryCommittees/ 

ucm111462.htm for procedures on 

public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: September 17, 2009. 

David Horowitz, 

Assistant Commissioner for Policy. 

[FR Doc. E9–22820 Filed 9–21–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

Anesthesiology and Respiratory 

Therapy Devices Panel of the Medical 

Devices Advisory Committee; Notice of 

Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Anesthesiology 

and Respiratory Therapy Devices Panel 


sroberts on DSKD5P82C1PROD with NOTICES